Skip to main content
Clinical Trials/EUCTR2014-005366-30-FI
EUCTR2014-005366-30-FI
Active, not recruiting
Phase 1

RESOLVING THE NEUROBIOLOGICAL MECHANISMS OF ANXIETY DISORDERS – BRAIN IMAGING SUB-STUDY

niversity of Helsinki0 sitesJune 29, 2016

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity of Helsinki
Status
Active, not recruiting
Last Updated
9 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 29, 2016
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
niversity of Helsinki

Eligibility Criteria

Inclusion Criteria

  • Social anxiety disorder, age 18\-65
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 70
  • F.1\.3 Elderly (\>\=65 years) no
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • Exclusion criteria are: borderline, schizoid or schizotypal personality, bipolar or any psychotic disorder; lifetime substance dependence, last\-year substance abuse, last month over 24/16 standard doses of alcohol/week; last month use of any illicit substance or last 3 month use of cannabis; unstable somatic illness; antidepressant medication use in last 4 months and use of antipsychotics, mood stabilizers, systemic corticosteroids, ß\-blockers or daytime benzodiazepines (a small dose of \=10mg zolpidem once daily is permissible).

Outcomes

Primary Outcomes

Not specified

Similar Trials